Ikena Oncology

IPO

Redefining targeted oncology therapies

Public · Boston, United States · Founded 2016 · $195.0M raised

Employees
11–50
Founded
2016
Business Model
B2B
Total Funding
$195.0M
Last Round
$75.0M Private EquityJul 2025
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 15 investors for this company. The full record is or through the API.

About

ImageneBio is a clinical-stage biotechnology company dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases with differentiated clinical profiles. The company is advancing olevaprubart, formerly IMG-007, an anti-OX40 antibody program for atopic dermatitis. Its management team brings decades of experience in R&D and has successfully driven drug candidates through every stage of development and commercialization.

Summary

Ikena Oncology is a Biotech company based in Boston, United States, founded in 2016. It has raised $195.0M in total across 3 rounds, most recently a $75.0M Private Equity round in Jul 2025. Investors include Omega Funds, OrbiMed and Atlas Venture.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Private EquityPrivate EquityJul 2025
$75.0M

Sign up to see all 3 events

Funding: Series A through Private Equity. Amounts, valuations, and investors where available.

Investors

Acquisitions

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ikena Oncology on Indexed.vc
<a href="https://indexed.vc/companies/ikena-oncology"><img src="https://indexed.vc/api/badge/company/ikena-oncology" alt="Ikena Oncology on Indexed.vc" width="260" height="76" /></a>